DK0804562T3 - Bindevævsvækstfaktor-2 - Google Patents

Bindevævsvækstfaktor-2

Info

Publication number: DK0804562T3
Authority: DK; Denmark
Prior art keywords: polypeptide; growth factor; connective tissue; tissue growth; enhancing
Prior art date: 1994-07-12

Application number

DK94925090T

Other languages

English (en)

Inventor

Haodong Li

D Adams Mark

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-12

Filing date

1994-07-12

Publication date

2003-02-10

1994-07-12 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2003-02-10 Application granted granted Critical

2003-02-10 Publication of DK0804562T3 publication Critical patent/DK0804562T3/da

Links

230000008473 connective tissue growth Effects 0.000 title 1
229920001184 polypeptide Polymers 0.000 abstract 5
102000004196 processed proteins & peptides Human genes 0.000 abstract 5
108090000765 processed proteins & peptides Proteins 0.000 abstract 5
230000002708 enhancing effect Effects 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
239000005557 antagonist Substances 0.000 abstract 1
239000007943 implant Substances 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1
238000010188 recombinant method Methods 0.000 abstract 1
230000006641 stabilisation Effects 0.000 abstract 1
238000011105 stabilization Methods 0.000 abstract 1
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cosmetics (AREA)

DK94925090T 1994-07-12 1994-07-12 Bindevævsvækstfaktor-2 DK0804562T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1994/007736 WO1996001896A1 (en)	1994-07-12	1994-07-12	Connective tissue growth factor-2

Publications (1)

Publication Number	Publication Date
DK0804562T3 true DK0804562T3 (da)	2003-02-10

Family

ID=22242737

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94925090T DK0804562T3 (da)	1994-07-12	1994-07-12	Bindevævsvækstfaktor-2

Country Status (10)

Country	Link
US (5)	US5945300A (da)
EP (2)	EP1217067A2 (da)
JP (1)	JPH10502534A (da)
AT (1)	ATE225850T1 (da)
AU (1)	AU689492B2 (da)
DE (1)	DE69431534T2 (da)
DK (1)	DK0804562T3 (da)
NZ (1)	NZ271488A (da)
PT (1)	PT804562E (da)
WO (1)	WO1996001896A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0804562T3 (da) *	1994-07-12	2003-02-10	Human Genome Sciences Inc	Bindevævsvækstfaktor-2
US7521540B2 (en)	1996-03-15	2009-04-21	Munin Corporation	CYR61 compositions and methods
US6790606B1 (en)	1996-03-15	2004-09-14	Munin Corporation	Extracellular matrix signaling molecules
JP4307552B2 (ja) *	1996-03-15	2009-08-05	ミューニンコーポレイション	細胞外マトリックスシグナリング分子
AU2004202578B2 (en) *	1996-03-15	2007-09-13	Munin Corporation	Extracellular matrix signalling molecules
US20090081228A1 (en) *	1996-03-15	2009-03-26	Munin Corporation	Cyr61 compositions and methods
US20040132987A1 (en)	1996-11-08	2004-07-08	Human Genome Sciences, Inc.	Connective tissue growth factor-3
AU7248798A (en) *	1997-04-16	1998-11-11	Millennium Pharmaceuticals, Inc.	Novel polypeptides within the growth factor superfamily
DE19719652A1 (de) *	1997-05-09	1998-12-03	Merckle Gmbh	Tissue-Faktor zur Förderung von Wundheilung
AU8901198A (en)	1997-08-06	1999-03-01	Millennium Pharmaceuticals, Inc.	Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
US5876730A (en) *	1997-08-07	1999-03-02	Childrens Hospital Research Foundation	Heparin-binding growth factor (HBGF) polypeptides
CA2321176A1 (en) *	1998-02-20	1999-08-26	Zymogenetics, Inc.	Connective tissue growth factor homologs
US6378527B1 (en) *	1998-04-08	2002-04-30	Chondros, Inc.	Cell-culture and polymer constructs
CN1170849C (zh) *	1998-12-14	2004-10-13	迈阿密大学	结缔组织生长因子片段及其方法和用途
US7115390B1 (en) *	1998-12-14	2006-10-03	Fibrogen, Inc.	Connective tissue growth factor fragments and methods and uses thereof
EP1892250A3 (en) *	2000-01-31	2008-09-17	Munin Corporation	CYR61 compositions and methods
US20060052328A1 (en) *	2000-07-11	2006-03-09	Human Genome Sciences, Inc.	Connective tissue growth factor-2
US20050153395A1 (en) *	2003-09-29	2005-07-14	Children's Hospital Inc.	Unique integrin binding site in connective tissue growth factor (CTGF)
TW201102086A (en)	2009-06-04	2011-01-16	Hoffmann La Roche	Antibodies against human CCN1 and uses thereof
WO2011107590A1 (en) *	2010-03-04	2011-09-09	Wolfgang Poller	Cnn1 (cyr61) for prevention and therapy of inflammatory disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988003409A1 (en)	1986-11-14	1988-05-19	Institute Of Molecular Biology, Inc.	Wound healing and bone regeneration
DK131988A (da)	1988-03-11	1989-09-12	Erasmus University	Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5648461A (en) *	1990-02-22	1997-07-15	W.R. Grace & Co.-Conn	Synthetic analogs of thrombospondin and therapeutic use thereof
JPH05255397A (ja) *	1991-01-18	1993-10-05	Bristol Myers Squibb Co	ＴＧＦ−β誘導遺伝子系統群
US5408040A (en) *	1991-08-30	1995-04-18	University Of South Florida	Connective tissue growth factor(CTGF)
US5837258A (en)	1991-08-30	1998-11-17	University Of South Florida	Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5270170A (en) *	1991-10-16	1993-12-14	Affymax Technologies N.V.	Peptide library and screening method
WO1994003599A1 (fr)	1992-08-04	1994-02-17	Sagami Chemical Research Center	ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
US7026299B2 (en) *	1994-07-12	2006-04-11	Human Genome Sciences, Inc.	Connective tissue growth factor-2
DK0804562T3 (da) *	1994-07-12	2003-02-10	Human Genome Sciences Inc	Bindevævsvækstfaktor-2
US5792453A (en)	1995-02-28	1998-08-11	The Regents Of The University Of California	Gene transfer-mediated angiogenesis therapy
JP4307552B2 (ja)	1996-03-15	2009-08-05	ミューニンコーポレイション	細胞外マトリックスシグナリング分子
US5944710A (en)	1996-06-24	1999-08-31	Genetronics, Inc.	Electroporation-mediated intravascular delivery
CN1170849C (zh)	1998-12-14	2004-10-13	迈阿密大学	结缔组织生长因子片段及其方法和用途
US20060052328A1 (en) *	2000-07-11	2006-03-09	Human Genome Sciences, Inc.	Connective tissue growth factor-2

1994
- 1994-07-12 DK DK94925090T patent/DK0804562T3/da active
- 1994-07-12 AT AT94925090T patent/ATE225850T1/de not_active IP Right Cessation
- 1994-07-12 EP EP02000398A patent/EP1217067A2/en not_active Withdrawn
- 1994-07-12 PT PT94925090T patent/PT804562E/pt unknown
- 1994-07-12 WO PCT/US1994/007736 patent/WO1996001896A1/en not_active Ceased
- 1994-07-12 AU AU75131/94A patent/AU689492B2/en not_active Ceased
- 1994-07-12 JP JP8504265A patent/JPH10502534A/ja active Pending
- 1994-07-12 NZ NZ271488A patent/NZ271488A/en not_active IP Right Cessation
- 1994-07-12 EP EP94925090A patent/EP0804562B1/en not_active Expired - Lifetime
- 1994-07-12 DE DE69431534T patent/DE69431534T2/de not_active Expired - Fee Related
1995
- 1995-06-02 US US08/459,101 patent/US5945300A/en not_active Expired - Fee Related
1999
- 1999-07-08 US US09/348,815 patent/US6534630B1/en not_active Expired - Fee Related
2002
- 2002-11-15 US US10/294,796 patent/US20030078391A1/en not_active Abandoned
2006
- 2006-11-28 US US11/563,870 patent/US20070154908A1/en not_active Abandoned
2009
- 2009-10-15 US US12/579,542 patent/US20100041136A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0804562A1 (en)	1997-11-05
EP0804562B1 (en)	2002-10-09
WO1996001896A1 (en)	1996-01-25
EP1217067A2 (en)	2002-06-26
AU689492B2 (en)	1998-04-02
DE69431534D1 (de)	2002-11-14
US20100041136A1 (en)	2010-02-18
JPH10502534A (ja)	1998-03-10
AU7513194A (en)	1996-02-09
ATE225850T1 (de)	2002-10-15
US6534630B1 (en)	2003-03-18
US20030078391A1 (en)	2003-04-24
DE69431534T2 (de)	2003-06-26
NZ271488A (en)	1998-01-26
EP0804562A4 (en)	1998-08-05
US20070154908A1 (en)	2007-07-05
US5945300A (en)	1999-08-31
PT804562E (pt)	2003-02-28

Publication	Publication Date	Title
DE69431534D1 (de)	2002-11-14	Bindegewebswachstumsfaktor-2
DK0759067T3 (da)	2001-10-22	Transformerende vækstfaktor alfa-H1
DK0751992T3 (da)	2006-03-06	Karendotelvækstfaktor 2
PT735818E (pt)	2004-07-30	Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y
DE69509628D1 (de)	1999-06-17	N-terminal chemisch modifizierte protein-zusammensetzungen und methoden
ATE259243T1 (de)	2004-02-15	Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
ATE295734T1 (de)	2005-06-15	Verwendung von fibroblasten-wachstumsfaktor analogen zur stimulation des knochenwachstums
DK0429570T3 (da)	1998-04-27	Osteoinducerende præparater
ATE238417T1 (de)	2003-05-15	Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
ATE153696T1 (de)	1997-06-15	Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
EE200200386A (et)	2003-12-15	Nogo-retseptoriga vahendatud aksonikasvu blokaad
DK0881908T3 (da)	2004-10-25	Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækst
GR3030141T3 (en)	1999-08-31	Diphtheria toxin receptor-binding region.
ATE510552T1 (de)	2011-06-15	Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
ATE346083T1 (de)	2006-12-15	Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
NO20000579L (no)	2000-02-25	Heparin-bindende vekstfaktor (HBGF) -polypeptider
DE60025830D1 (de)	2006-04-13	Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
DK29889A (da)	1989-07-26	Heparinbindende hjernemitogener, deres fremstilling og anvendelse
WO2002004480A3 (en)	2003-10-16	Connective tissue growth factor-2
EP0832109A4 (en)	2000-06-14	FACTOR-2, HOMOLOGY OF THE FIBROBLASTS GROWTH FACTOR AND METHOD FOR ITS APPLICATION
RU95108616A (ru)	1997-03-27	Способ лечения верхней ретро- или микрогнатии, осложненной расщелиной твердого неба и альвеолярного отростка
ES2180585T3 (es)	2003-02-16	Factor de crecimiento de tejido conjuntivo-2.
WO2001075008A3 (fr)	2002-02-07	Nouveau polypeptide, protéine hélicase-anneau-hélicase 11, et polynucleotide codant pour ce polypeptide
RU95109007A (ru)	1997-03-27	Способ лечения верхней ретро- или микрогнатии
RU97116344A (ru)	1999-08-10	Способ удлинения конечности